Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Mild Pre-eclampsia
NCT03262961Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ASP-001 in preeclampsia (2 arms), sponsored by Assiut University. Primary endpoint: Gestational age at time of termination and maternal outcome. Status: unknown.
02
Drugs
ASP-001
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03262961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03262961.